629 related articles for article (PubMed ID: 18202658)
1. Identification of RPS14 as a 5q- syndrome gene by RNA interference screen.
Ebert BL; Pretz J; Bosco J; Chang CY; Tamayo P; Galili N; Raza A; Root DE; Attar E; Ellis SR; Golub TR
Nature; 2008 Jan; 451(7176):335-9. PubMed ID: 18202658
[TBL] [Abstract][Full Text] [Related]
2. Molecular pathogenesis in Diamond-Blackfan anemia.
Ito E; Konno Y; Toki T; Terui K
Int J Hematol; 2010 Oct; 92(3):413-8. PubMed ID: 20882441
[TBL] [Abstract][Full Text] [Related]
3. Haploinsufficiency for ribosomal protein genes causes selective activation of p53 in human erythroid progenitor cells.
Dutt S; Narla A; Lin K; Mullally A; Abayasekara N; Megerdichian C; Wilson FH; Currie T; Khanna-Gupta A; Berliner N; Kutok JL; Ebert BL
Blood; 2011 Mar; 117(9):2567-76. PubMed ID: 21068437
[TBL] [Abstract][Full Text] [Related]
4. Genetic deletions in AML and MDS.
Ebert BL
Best Pract Res Clin Haematol; 2010 Dec; 23(4):457-61. PubMed ID: 21130407
[TBL] [Abstract][Full Text] [Related]
5. A Zebrafish Model of 5q-Syndrome Using CRISPR/Cas9 Targeting RPS14 Reveals a p53-Independent and p53-Dependent Mechanism of Erythroid Failure.
Ear J; Hsueh J; Nguyen M; Zhang Q; Sung V; Chopra R; Sakamoto KM; Lin S
J Genet Genomics; 2016 May; 43(5):307-18. PubMed ID: 27216296
[TBL] [Abstract][Full Text] [Related]
6. Diminutive somatic deletions in the 5q region lead to a phenotype atypical of classical 5q- syndrome.
Vlachos A; Farrar JE; Atsidaftos E; Muir E; Narla A; Markello TC; Singh SA; Landowski M; Gazda HT; Blanc L; Liu JM; Ellis SR; Arceci RJ; Ebert BL; Bodine DM; Lipton JM
Blood; 2013 Oct; 122(14):2487-90. PubMed ID: 23943650
[TBL] [Abstract][Full Text] [Related]
7. Activation of the mTOR pathway by the amino acid (L)-leucine in the 5q- syndrome and other ribosomopathies.
Boultwood J; Yip BH; Vuppusetty C; Pellagatti A; Wainscoat JS
Adv Biol Regul; 2013 Jan; 53(1):8-17. PubMed ID: 23031788
[TBL] [Abstract][Full Text] [Related]
8. [Ribosomal protein in impaired erythropoiesis: Diamond-Blackfan anemia and 5q- syndrome].
Ito E
Rinsho Ketsueki; 2009 Oct; 50(10):1539-47. PubMed ID: 19915364
[No Abstract] [Full Text] [Related]
9. Coordinate loss of a microRNA and protein-coding gene cooperate in the pathogenesis of 5q- syndrome.
Kumar MS; Narla A; Nonami A; Mullally A; Dimitrova N; Ball B; McAuley JR; Poveromo L; Kutok JL; Galili N; Raza A; Attar E; Gilliland DG; Jacks T; Ebert BL
Blood; 2011 Oct; 118(17):4666-73. PubMed ID: 21873545
[TBL] [Abstract][Full Text] [Related]
10. Haploinsufficiency of RPS14 in 5q- syndrome is associated with deregulation of ribosomal- and translation-related genes.
Pellagatti A; Hellström-Lindberg E; Giagounidis A; Perry J; Malcovati L; Della Porta MG; Jädersten M; Killick S; Fidler C; Cazzola M; Wainscoat JS; Boultwood J
Br J Haematol; 2008 Jul; 142(1):57-64. PubMed ID: 18477045
[TBL] [Abstract][Full Text] [Related]
11. L-Leucine improves the anaemia in models of Diamond Blackfan anaemia and the 5q- syndrome in a TP53-independent way.
Narla A; Payne EM; Abayasekara N; Hurst SN; Raiser DM; Look AT; Berliner N; Ebert BL; Khanna-Gupta A
Br J Haematol; 2014 Nov; 167(4):524-528. PubMed ID: 25098371
[TBL] [Abstract][Full Text] [Related]
12. Non-Diamond Blackfan anemia disorders of ribosome function: Shwachman Diamond syndrome and 5q- syndrome.
Burwick N; Shimamura A; Liu JM
Semin Hematol; 2011 Apr; 48(2):136-43. PubMed ID: 21435510
[TBL] [Abstract][Full Text] [Related]
13. L-Leucine improves the anemia and developmental defects associated with Diamond-Blackfan anemia and del(5q) MDS by activating the mTOR pathway.
Payne EM; Virgilio M; Narla A; Sun H; Levine M; Paw BH; Berliner N; Look AT; Ebert BL; Khanna-Gupta A
Blood; 2012 Sep; 120(11):2214-24. PubMed ID: 22734070
[TBL] [Abstract][Full Text] [Related]
14. Mice with a Mutation in the Mdm2 Gene That Interferes with MDM2/Ribosomal Protein Binding Develop a Defect in Erythropoiesis.
Kamio T; Gu BW; Olson TS; Zhang Y; Mason PJ; Bessler M
PLoS One; 2016; 11(4):e0152263. PubMed ID: 27042854
[TBL] [Abstract][Full Text] [Related]
15. Rps14 haploinsufficiency causes a block in erythroid differentiation mediated by S100A8 and S100A9.
Schneider RK; Schenone M; Ferreira MV; Kramann R; Joyce CE; Hartigan C; Beier F; Brümmendorf TH; Germing U; Platzbecker U; Büsche G; Knüchel R; Chen MC; Waters CS; Chen E; Chu LP; Novina CD; Lindsley RC; Carr SA; Ebert BL
Nat Med; 2016 Mar; 22(3):288-97. PubMed ID: 26878232
[TBL] [Abstract][Full Text] [Related]
16. Establishing Rps6 hemizygous mice as a model for studying how ribosomal protein haploinsufficiency impairs erythropoiesis.
Keel SB; Phelps S; Sabo KM; O'Leary MN; Kirn-Safran CB; Abkowitz JL
Exp Hematol; 2012 Apr; 40(4):290-4. PubMed ID: 22198155
[TBL] [Abstract][Full Text] [Related]
17. Acquired ribosomopathies in leukemia and solid tumors.
Vlachos A
Hematology Am Soc Hematol Educ Program; 2017 Dec; 2017(1):716-719. PubMed ID: 29222326
[TBL] [Abstract][Full Text] [Related]
18. Cancer: hay in a haystack.
Shannon KM; Le Beau MM
Nature; 2008 Jan; 451(7176):252-3. PubMed ID: 18202630
[No Abstract] [Full Text] [Related]
19. Rps14, Csnk1a1 and miRNA145/miRNA146a deficiency cooperate in the clinical phenotype and activation of the innate immune system in the 5q- syndrome.
Ribezzo F; Snoeren IAM; Ziegler S; Stoelben J; Olofsen PA; Henic A; Ferreira MV; Chen S; Stalmann USA; Buesche G; Hoogenboezem RM; Kramann R; Platzbecker U; Raaijmakers MHGP; Ebert BL; Schneider RK
Leukemia; 2019 Jul; 33(7):1759-1772. PubMed ID: 30651631
[TBL] [Abstract][Full Text] [Related]
20. Deletion 5q MDS: molecular and therapeutic implications.
Komrokji RS; Padron E; Ebert BL; List AF
Best Pract Res Clin Haematol; 2013 Dec; 26(4):365-75. PubMed ID: 24507813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
